Global

Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs Hospitalized COVID-19 patients treated with the antiviral drug nirmatrelvir–ritonavir (Paxlovid) are at lower risk for death, intensive care unit (ICU) admission, and need for ventilation than those given a combination of Paxlovid and the antiviral drug remdesivir (Veklury) or Veklury alone, a University of Hong Kong target trial emulation study suggests. CIDRAP

...

UN Expert on Climate Change and Human Rights Sees ‘Crucial and Urgent Demand’ to Clarify Governments’ Obligations - Inside Climate News “The world hasn’t been making progress on this fast enough.” Elisa Morgera’s role is to get countries thinking about, and acting on, the many human rights consequences of the climate crisis. Derek Harrison Inside Climate News

...

1 in 10 pregnant women with COVID-19 go on to develop long COVID, study finds A new study suggests that almost 1 in 10 women infected with COVID-19 during pregnancy will go on to develop long COVID. The study was published yesterday in Obstetrics & Gynecology and adds to evidence showing COVID-19 infection posing unique risks to pregnant women.  CIDRAP

...

Prior research has shown that pregnant women infected with the virus are more likely to suffer hospitalization and death compared to non-pregnant controls. COVID in pregnancy also leads to a higher risk of stillbirth and preterm birth.

...